7 research outputs found
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
[No abstract available]Support statement: C. Lange is supported by the German Center of Infection Research (DZIF). All other authors have no funding to declare for this study. Funding information for this article has been deposited with the Crossref Funder Registry